3rd

Article

Obesity may reduce efficacy of psoriasis therapies

Psoriasis is strongly associated with obesity, which can reduce the efficacy of biologic and conventional therapies, increase side effects, and affect drug survival. An expert panel reviewed available evidence and developed consensus recommendations to optimize care for this population. Weight control is an essential component of psoriasis management, alongside expanding therapeutic options.

Article

Risk of death higher in people with vs without psoriasis

Psoriatic disease is linked to an increased risk of all-cause mortality compared to individuals without the condition, even after adjusting for comorbidities. The risk appears higher in psoriasis but not in psoriatic arthritis, with a possible increase among those receiving biologic therapy.

Login